L-DOPA-induced dyskinesia in the intrastriatal 6-hydroxydopamine model of Parkinson's disease: Relation to motor and cellular parameters of nigrostriatal function

Neurobiology of Disease

Volumn 10, Issue 2, 2002, Pages 165-186

  Winkler, Christian ^a,b   Kirik, Deniz ^a   Björklund, Anders ^a   Cenci, M Angela ^a  

^a LUND UNIVERSITY   (Sweden)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Basal ganglia; Behaviour; Delta fosB; Dynorphin; Enkephalin; Motor complications; Sensitization

Indexed keywords

6 HYDROXYTRYPTAMINE; LEVODOPA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BRAIN NERVE CELL; CAUDATE NUCLEUS; CONTROLLED STUDY; DENERVATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; DOPAMINERGIC NERVE CELL; DRUG SAFETY; DRUG SENSITIVITY; DYSKINESIA; FEMALE; FOREBRAIN; FORELIMB; IMMUNOREACTIVITY; MOTOR PERFORMANCE; NERVE CELL LESION; NERVE FIBER; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PUTAMEN; RAT; SKELETAL MUSCLE;

EID: 0036070538     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1006/nbdi.2002.0499     Document Type: Article

References (44)

1. Estimation of nuclear population from microtome sections
2. Striatal fosB expression is causally linked with L-DOPA-induced abnormal involuntary movements and the associated upregulation of striatal prodynorphin mRNA in a rat model of Parkinson's disease
3. cAMP response element-binding protein is required for dopamine-dependent gene expression in the intact but not the dopamine-denervated striatum
4. Evaluation of simple and complex sensorimotor behaviours in rats with a partial lesion of the dopaminergic nigrostriatal system
5. Effects of complete and partial lesions of the dopaminergic mesotelencephalic system on skilled forelimb use in the rat
6. Dopamine-receptor stimulation: Biobehavioral and biochemical consequences
7. Dopaminergic transplants normalize amphetamine- and apomorphine-induced Fos expression in the 6-hydroxydopamine-lesioned striatum
8. Neuropeptide messenger RNA expression in the 6-hydroxydopamine lesioned rat striatum reinnervated by fetal dopaminergic transplants: Differential effects of the grafts on preproenkephalin, preprotachykinin, and prodynorphin messenger RNA levels
9. L-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA
10. Biochemical and anatomical characterization of forepaw adjusting steps in rat models of Parkinson's disease: Studies on medial forebrain bundle and striatal lesions
11. Levodopa therapy: Consequences of the nonphysiologic replacement of dopamine
12. Sequence and expression of the rat prodynorphin gene
13. Glial cell line-derived neurotrophic factor (GDNF) gene delivery protects dopaminergic terminals from degeneration
14. Immunophilin ligands can prevent progressive dopaminergic degeneration in animal models of Parkinson's disease
15. Oral stereotypy induced by amphetamine microinjection into striatum: An anatomical mapping study
16. The spectrum of levodopa-induced dyskinesias
17. Anatomy of the basal ganglia
18. Molecular cloning and sequence determination of rat preproenkephalin cDNA: Sensitive probe for studying transcriptional changes in rat tissues
19. Effects of anaesthetics and lazaroid U-83836E on survival of transplanted rat dopaminergic neurones
20. Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat
21. Longterm rAAV-mediated gene transfer of GDNF in the rat Parkinson's model: Intrastriatal but not intranigral transduction promotes functional regeneration in the lesioned nigrostriatal system
22. Growth and functional efficacy of intrastriatal nigral transplants depend on the extent of nigrostriatal degeneration
23. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications
24. Embryonic ventral mesencephalic grafts improve levodopa-induced dyskinesia in a rat model of Parkinson's disease
25. Dopaminergic neuronal degeneration and motor impairments following axon terminal lesion by instrastriatal 6-hydroxydopamine in the rat
26. Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease
27. The "staircase test": A measure of independent forelimb reaching and grasping abilities in rats
28. Pathogenesis of dyskinesias in Parkinson's disease
29. Microtransplantation of nigral dopamine neurons: A step-by-step recipe
30. Levodopa-induced dyskinesia: Review, observations and speculations
31. Levodopa motor complications in Parkinson's disease
32. Forelimb akinesia in the rat Parkinson model: Differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test
33. Motor functions of the striatum in the rat: Critical role of the lateral region in tongue and forelimb reaching
34. Ventrolateral striatal dopamine depletions impair feeding and food handling in rats
35. Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: A combined retrograde tracing and immunocytochemical study in the rat
36. Intervention strategies for degeneration of dopamine neurons in parkinsonism: Optimizing behavioral assessment of outcome
37. Electrophysiological and in vitro electrochemical recordings in rats with intraventricular human xenografts
38. Stereological methods for estimating the total number of neurons and synapses: Issues of precision and bias
39. Persistent changes in striatal gene expression induced by long-term L-DOPA treatment in a rat model of Parkinson's disease
40. Intranigral transplants of GABA-rich striatal tissue induce behavioral recovery in the rat Parkinson model and promote the effects obtained by intrastriatal dopaminergic transplants
41. Transplantation in the rat model of Parkinson's disease: Ectopic versus homotopic graft placement
42. Short-term GDNF treatment provides long-term rescue of lesioned nigral dopaminergic neurons in a rat model of Parkinson's disease
43. Compensations after lesions of central dopaminergic neurons: Some clinical and basic implications